SCHEMBL6133357

SCHEMBL6133357

CCOC(=O)c1nc(-c2cccc(F)c2)c(-c2ccc(=O)n(C(C)C)n2)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.45
PTGS2 P35354 1/20 0.44
MET P08581 1/20 0.40
CSNK1D P48730 1/20 0.40
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
KDM4E B2RXH2 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
RORC P51449 1/20 0.37
NPSR1 Q6W5P4 3/20 0.37
HSD17B10 Q99714 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133413 0.89 PDE4A (0.46) TRPM8PTGS2ALDH1A1KDM4EL3MBTL1
SCHEMBL6133158 0.89 PTGS2 (0.56) TRPM8PTGS2ALDH1A1HPGDKDM4E
SCHEMBL6133924 0.89 PTGS2 (0.44) TRPM8PTGS2ALDH1A1HPGDKDM4E
SCHEMBL6134138 0.86 RORC (0.40) TRPM8METCSNK1DALDH1A1KDM4E
SCHEMBL6133334 0.86 HPGDS (0.38) TRPM8CSNK1DJAK2JAK3RORC
SCHEMBL6133353 0.84 ALDH1A1 (0.47) PTGS2ALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL6134062 0.81 MAP4K4 (0.41) CSNK1DKMT2ARORC
SCHEMBL6133824 0.80 MAPT (0.39) TRPM8METALDH1A1KDM4EMAPT
SCHEMBL6134645 0.80 ADORA2A (0.49) ALDH1A1HPGDKDM4EL3MBTL1MEN1
SCHEMBL6134322 0.76 PTGS2 (0.46) TRPM8PTGS2ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR TRPM8 1010/4885PTGS2 1262/4885MET 239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.